788 related articles for article (PubMed ID: 30813783)
21. Clinical outcome of central conventional chondrosarcoma.
Angelini A; Guerra G; Mavrogenis AF; Pala E; Picci P; Ruggieri P
J Surg Oncol; 2012 Dec; 106(8):929-37. PubMed ID: 22649023
[TBL] [Abstract][Full Text] [Related]
22. A Novel System for the Surgical Staging of Primary High-grade Osteosarcoma: The Birmingham Classification.
Jeys LM; Thorne CJ; Parry M; Gaston CL; Sumathi VP; Grimer JR
Clin Orthop Relat Res; 2017 Mar; 475(3):842-850. PubMed ID: 27138473
[TBL] [Abstract][Full Text] [Related]
23. Is intralesional resection suitable for central grade 1 chondrosarcoma: A systematic review and updated meta-analysis.
Chen X; Yu LJ; Peng HM; Jiang C; Ye CH; Zhu SB; Qian WW
Eur J Surg Oncol; 2017 Sep; 43(9):1718-1726. PubMed ID: 28666625
[TBL] [Abstract][Full Text] [Related]
24. Survival analysis of patients with chondrosarcomas of the pelvis.
Mavrogenis AF; Angelini A; Drago G; Merlino B; Ruggieri P
J Surg Oncol; 2013 Jul; 108(1):19-27. PubMed ID: 23681650
[TBL] [Abstract][Full Text] [Related]
25. Differences in clinical characteristics and tumor prognosis between primary and secondary conventional pelvic chondrosarcoma.
Zang J; Guo W; Yang R; Tang X; Liang H
BMC Cancer; 2020 Nov; 20(1):1054. PubMed ID: 33138794
[TBL] [Abstract][Full Text] [Related]
26. Prognosis of Primary and Recurrent Chondrosarcoma of the Rib.
Roos E; van Coevorden F; Verhoef C; Wouters MW; Kroon HM; Hogendoorn PC; van Houdt WJ
Ann Surg Oncol; 2016 Mar; 23(3):811-7. PubMed ID: 26498768
[TBL] [Abstract][Full Text] [Related]
27. Is computer navigation when used in the surgery of iliosacral pelvic bone tumours safer for the patient?
Laitinen MK; Parry MC; Albergo JI; Grimer RJ; Jeys LM
Bone Joint J; 2017 Feb; 99-B(2):261-266. PubMed ID: 28148671
[TBL] [Abstract][Full Text] [Related]
28. Chondrosarcoma of the pelvis.
Ozaki T; Hillmann A; Lindner N; Blasius S; Winkelmann W
Clin Orthop Relat Res; 1997 Apr; (337):226-39. PubMed ID: 9137194
[TBL] [Abstract][Full Text] [Related]
29. Chondrosarcoma of the hands and feet.
Kask G; Laitinen MK; Stevenson J; Evans S; Jeys LM; Parry MC
Bone Joint J; 2021 Mar; 103-B(3):562-568. PubMed ID: 33641425
[TBL] [Abstract][Full Text] [Related]
30. Low-grade chondrosarcoma of long bones treated with intralesional curettage followed by application of phenol, ethanol, and bone-grafting.
Verdegaal SH; Brouwers HF; van Zwet EW; Hogendoorn PC; Taminiau AH
J Bone Joint Surg Am; 2012 Jul; 94(13):1201-7. PubMed ID: 22760388
[TBL] [Abstract][Full Text] [Related]
31. Advancing patient age is associated with worse outcomes in low- and intermediate-grade primary chondrosarcoma of the pelvis.
Houdek MT; Witten BG; Hevesi M; Griffin AM; Salduz A; Wenger DE; Sim FH; Ferguson PC; Rose PS; Wunder JS
J Surg Oncol; 2020 Mar; 121(4):638-644. PubMed ID: 31989655
[TBL] [Abstract][Full Text] [Related]
32. Are Limb-sparing Surgical Resections Comparable to Amputation for Patients With Pelvic Chondrosarcoma? A Case-control, Propensity Score-matched Analysis of the National Cancer Database.
Kim CY; Collier CD; Liu RW; Getty PJ
Clin Orthop Relat Res; 2019 Mar; 477(3):596-605. PubMed ID: 30762693
[TBL] [Abstract][Full Text] [Related]
33. The role of grade in local recurrence and the disease-specific survival in chondrosarcomas.
Laitinen MK; Stevenson JD; Parry MC; Sumathi V; Grimer RJ; Jeys LM
Bone Joint J; 2018 May; 100-B(5):662-666. PubMed ID: 29701096
[TBL] [Abstract][Full Text] [Related]
34. Chondrosarcoma of bone: an assessment of outcome.
Lee FY; Mankin HJ; Fondren G; Gebhardt MC; Springfield DS; Rosenberg AE; Jennings LC
J Bone Joint Surg Am; 1999 Mar; 81(3):326-38. PubMed ID: 10199270
[TBL] [Abstract][Full Text] [Related]
35. Survival, local recurrence, and function after pelvic limb salvage at 23 to 38 years of followup.
Sherman CE; O'Connor MI; Sim FH
Clin Orthop Relat Res; 2012 Mar; 470(3):712-27. PubMed ID: 21748513
[TBL] [Abstract][Full Text] [Related]
36. Metastatic Potential of Grade I Chondrosarcoma of Bone: Results of a Multi-institutional Study.
Andreou D; Gilg MM; Gosheger G; Werner M; Hardes J; Pink D; Leithner A; Tunn PU; Streitbürger A
Ann Surg Oncol; 2016 Jan; 23(1):120-5. PubMed ID: 26350369
[TBL] [Abstract][Full Text] [Related]
37. Grade I chondrosarcoma of bone: the Münster experience.
Streitbürger A; Ahrens H; Balke M; Buerger H; Winkelmann W; Gosheger G; Hardes J
J Cancer Res Clin Oncol; 2009 Apr; 135(4):543-50. PubMed ID: 18855011
[TBL] [Abstract][Full Text] [Related]
38. Dedifferentiated chondrosarcoma--a fatal disease.
Bruns J; Fiedler W; Werner M; Delling G
J Cancer Res Clin Oncol; 2005 Jun; 131(6):333-9. PubMed ID: 15785935
[TBL] [Abstract][Full Text] [Related]
39. Survival and prognostic factors in chondrosarcoma: results in 115 patients with long-term follow-up.
Andreou D; Ruppin S; Fehlberg S; Pink D; Werner M; Tunn PU
Acta Orthop; 2011 Dec; 82(6):749-55. PubMed ID: 22066552
[TBL] [Abstract][Full Text] [Related]
40. What Factors Are Associated with Treatment Outcomes of Japanese Patients with Clear Cell Chondrosarcoma?
Nakayama R; Hayakawa K; Kobayashi E; Endo M; Asano N; Yonemoto T; Kawashima H; Hamada K; Watanabe I; Futani H; Goto T; Nishida Y; Ozaki T
Clin Orthop Relat Res; 2020 Nov; 478(11):2537-2547. PubMed ID: 32297725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
